Breast cancer
Targeted antibodies:
- Scaituzumab govitecan
Scaituzumab govitecan is an antibody medication conjugate which kills the cancer cells by working on the TROP-2 pathway and works best for the patients with triple negative breast cancer (TNBC).
- Pertuzumab
Pertuzumab is a monoclonal antibody which kills the HER2 pathway cancer cells and works best specifically for the patients with HER-2 positive breast cancer.
- Trastuzumab
Trastuzumab is one of the monoclonal antibody medication conjugate that kills the cancer cells on the HER2 pathway and supplies toxic drugs to cancer cells. It works best for patients with advanced HER2 breast cancer.
- Trastuzumab emtansine
Trastuzumab emtansine is an antibody and drug conjugate which kills the cancer cells by working on the HER2 pathway. It is a best choice of treatment for patients having HER-2 positive breast cancer.
- Trastuzumab deruxtecan
Trastuzumab deruxtecan is a conjugate of antibody and drug that kills the cancer cells on HER2 pathway and supplies toxic drugs to tumor cells so that they can burst easily. It works best for patients having advanced HER2 positive breast cancer.